Skoči na glavni sadržaj

Ostalo

https://doi.org/10.15836/ccar2022.199

Effusive-constrictive pericarditis as a complication of long-term treatment with adalimumab

Mira Stipcevic orcid id orcid.org/0000-0003-4351-1102 ; Zadar General Hospital, Zadar, Croatia
Drazen Zekanovic orcid id orcid.org/0000-0002-8147-6574 ; Zadar General Hospital, Zadar, Croatia
Jogen Patrk ; Zadar General Hospital, Zadar, Croatia
Igor Rudez orcid id orcid.org/0000-0002-7735-6721 ; Dubrava University Hospital, Zagreb, Croatia
Zoran Bakotic orcid id orcid.org/0000-0002-7095-0111 ; Zadar General Hospital, Zadar, Croatia
Marin Bistirlic orcid id orcid.org/0000-0002-9213-4174 ; Zadar General Hospital, Zadar, Croatia
Zorislav Susak orcid id orcid.org/0000-0002-2417-2494 ; Zadar General Hospital, Zadar, Croatia
Branimir Buksa ; Zadar General Hospital, Zadar, Croatia
Stipe Kosor orcid id orcid.org/0000-0002-2813-9026 ; Zadar General Hospital, Zadar, Croatia
Karla Savic orcid id orcid.org/0000-0002-1339-8922 ; Zadar General Hospital, Zadar, Croatia
Kresimir Librenjak orcid id orcid.org/0000-0002-4168-6120 ; Zadar General Hospital, Zadar, Croatia


Puni tekst: engleski pdf 1.726 Kb

str. 199-200

preuzimanja: 189

citiraj

Preuzmi JATS datoteku


Sažetak

Ključne riječi

constrictive pericarditis; adalimumab; pericardiectomy

Hrčak ID:

287112

URI

https://hrcak.srce.hr/287112

Datum izdavanja:

8.12.2022.

Posjeta: 578 *



Introduction: Inhibitors of tumor necrosis factor-α are frequently encountered in modern clinical practice for treatment of psoriatic arthritis and opportunistic infections are in that context a common concern. Infective pericarditis has been described as a complication of these treatments (1). In most cases patients present with acute pericarditis, caused by wide spectrum bacteria, and can lead to cardiac tamponade and acute heart failure. Some patients present with symptoms of pericardial constriction (2).

Case report: We present a case of sixty-year-old patient who was treated for psoriatic arthritis for fifteen years, and due to recurrent polychondritis adalimumab was introduced in therapy two years ago. The patient had good response to treatment, without side effects. In January 2021 he presented with symptoms of fatigue, swollen abdomen, difficulty breathing, swelling of legs and weakness. Symptoms started two months earlier. There were no signs of acute infectious illness. Echocardiography revealed thickened pericardium and moderate circumferential pericardial effusion, with respirophasic interventricular septal motion. Computed tomography showed thickened and calcified pericardium (Figure 1). Finally, heart catheterization confirmed the reciprocal respiratory pressure changes in the right and left ventricle (Figure 2). The patient’s symptoms of constrictive heart failure persisted and led to surgical treatment consisting of radical pericardiectomy and decortication (Figure 3). No pathogen was identified in pericardial fluid and pathohistological examination of pericardium showed chronic inflammation. The patient recovered completely and was without symptoms ten months later.

FIGURE 1 Computed tomography showing thickened and calcified pericardium.
CC202217_9-10_199-200-f1
FIGURE 2 Heart catheterization confirming the reciprocal respiratory pressure changes in the right and left ventricle.
CC202217_9-10_199-200-f2

Conclusion: Prolonged treatment with adalimumab can pave the way to opportunistic infections which can cause acute pericarditis. In some cases, it can lead to chronic inflammation with late onset of chronic pericarditis. In case of constrictive pericarditis with severe and persistent hemodynamic impairment which cannot be controlled by medical therapy surgical pericardiectomy should be considered (3).

FIGURE 3 Thickened and calcified pericardium (A). Excised pericardium (B).
CC202217_9-10_199-200-f3

LITERATURE

1 

Ozkan H, Cetinkaya AS, Yildiz T, Bozat T. A Rare Side Effect due to TNF-Alpha Blocking Agent: Acute Pleuropericarditis with Adalimumab. Case Rep Rheumatol. 2013;2013:985914. https://doi.org/10.1155/2013/985914 PubMed: http://www.ncbi.nlm.nih.gov/pubmed/23970991

2 

Nakamura Y, Izumi C, Nakagawa Y, Hatta K. A case of effusive-constrictive pericarditis accompanying rheumatoid arthritis: The possibility of adverse effect of TNF-inhibitor therapy. J Cardiol Cases. 2012 September 25;7(1):e8–10. https://doi.org/10.1016/j.jccase.2012.08.007 PubMed: http://www.ncbi.nlm.nih.gov/pubmed/30533107

3 

Depboylu BC, Mootoosamy P, Vistarini N, Testuz A, El-Hamamsy I, Cikirikcioglu M. Surgical Treatment of Constrictive Pericarditis. Tex Heart Inst J. 2017 April 1;44(2):101–6. https://doi.org/10.14503/THIJ-16-5772 PubMed: http://www.ncbi.nlm.nih.gov/pubmed/28461794


This display is generated from NISO JATS XML with jats-html.xsl. The XSLT engine is libxslt.